ME 23andMe Inc.: Wutah pendapatan triwulanan

Simbol lan logo merek 23andMe Inc. (ME)

Risks for 23andMe Holding Co. (ME) are linked to discretionary demand for DNA tests and vulnerability to crises. On the GURU.Markets platform, the percentage growth of quarterly revenue visualizes these fluctuations, where the 34.40 mark indicates the current state. Stability is provided by its status as a pioneer of personalized genetics with the largest database, as well as its independence from macroeconomics due to the demand for innovative medical developments.

23andMe Holding Co (ME) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 05.04.2025

Rincian analitis lan laporan data perusahaan 23andMe Holding Co (ME)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Pambiji fundamental perusahaan:23andMe (ME)
Produk seri 23andMe

23andMe Holding Co. (ME) leverages diversification through the synthesis of consumer genetic testing and pharmaceutical development, allowing the company to monetize a unique DNA dataset for drug discovery. By analyzing the quarterly revenue history on GURU.Markets, an investor can assess the percentage growth in sales relative to the same period last year, which confirms a recovery in demand and determines capital stability without the risk of overpaying for success already priced in.

Pesaing langsung

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Tingkat wutah pendapatan sajrone kuartal|Insight Molecular Diagnostics Inc - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal trinitybiotech.com|PRPH (ProPhase) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal AIMD|Wutah dodolan triwulanan CODX|Tingkat wutah pendapatan sajrone kuartal heartsciences.com HSCS|Wutah pendapatan kuartal marang kuartal Biomerica Inc. (BMRA)|Tingkat wutah dodolan sajrone kuartal Cardio Diagnostics Holdings|Wutah pendapatan triwulanan ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Tingkat wutah pendapatan sajrone kuartal|bluejaydx.com - Wutah pendapatan triwulanan|Aspira Women's Health - Owah-owahan dodolan kuartal marang kuartal|AXDX (Accelerate Diagnostics) - Wutah dodolan triwulanan|Wutah dodolan triwulanan CENTOGENE, N.V.|Wutah pendapatan kuartal marang kuartal enzo.com|Wutah pendapatan triwulanan Fresh2 Group Limited|Wutah pendapatan triwulanan GENE|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)